Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization

Pneumococcal pneumonia is a significant health concern for pediatric, healthy adult, and elderly populations. The newly licensed pneumococcal 7-valent conjugate (diphtheria CRM197 protein) vaccine, Prevnar, and a second generation experimental 9-valent product have demonstrated, for the first time,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Mechanisms of ageing and development 2004-02, Vol.125 (2), p.147-148
Hauptverfasser:	Parijs, Betsy Abraham-Van, Malinoski, Frank J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adult immunization Biological and medical sciences Development. Metamorphosis. Moult. Ageing Fundamental and applied biological sciences. Psychology Heptavalent Pneumococcal Conjugate Vaccine Humans Meningococcal Vaccines - therapeutic use Pneumococcal vaccine Pneumococcal Vaccines - therapeutic use Pneumonia, Pneumococcal - prevention & control Product Surveillance, Postmarketing Vaccines Vaccines, Conjugate - therapeutic use Vertebrates: anatomy and physiology, studies on body, several organs or systems
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!